Glaucoma Adherence Study, Spain

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Ocular HypertensionPrimary Open Angle Glaucoma
Interventions
DRUG

Travoprost 0.004%/timolol 0.05% fixed combination eye drops (DuoTrav)

One drop in study eye(s) once daily in the evening for four months

DEVICE

Travalert Dosing Aid

Approved device used with DuoTrav and intended to provide an objective system for quantifying dosing and improving patient adherence

Trial Locations (1)

28040

Spain, Madrid

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00680329 - Glaucoma Adherence Study, Spain | Biotech Hunter | Biotech Hunter